A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- Eli Lilly and Company
- Study ID
- NCT03559270
- Phase
- PHASE3
- Status
- Terminated
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Baricitinib — DRUGAdministered orally
Study Details
This open-label study will evaluate the long-term efficacy and safety of baricitinib in adult participants with moderate to severe atopic dermatitis (AD).
Key Dates
- Start date
- Jun 27, 2018
- Status verified
- Oct 2022
- Primary completion
- Oct 14, 2021
- Completion
- Jun 13, 2022
Study Design
- Enrollment
- 374 participants (actual)
- Allocation
- NON_RANDOMIZED
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Placebo/Baricitinib 2-milligram (mg)Open-label 2 mg baricitinib administered orally once daily (QD) to participants who randomized to placebo in the originating study (JAIW).
- Experimental: Baricitinib 1-mg/Baricitinib 2-mgOpen-label 2 mg baricitinib administered orally QD to participants who randomized to 1 mg baricitinib in the originating study (JAIW).
- Experimental: Baricitinib 2-mg/Baricitinib 2-mgOpen-label 2 mg baricitinib administered orally QD to participants who randomized to 2 mg baricitinib in the originating study (JAIW).
- Experimental: Baricitinib 2-mg Open-Label AddendumParticipants were directly enrolled to receive open-label 2 mg baricitinib orally QD.
Primary Outcome Measure
Percentage of Participants Achieving Eczema Area and Severity Index 75 (EASI75) [ Time Frame: Week 16 ]
Locations (53)
Find similar trials in Birmingham, AL
By condition
By specialty
By research site
University of Alabama at Birmingham· Birmingham, ALJohnson Dermatology· Fort Smith, ARCalifornia Dermatology & Clinical Research Institute· Encinitas, CAFirst OC Dermatology· Fountain Valley, CACenter For Dermatology Clinical Research, Inc.· Fremont, CAKeck School of Medicine University of Southern California· Los Angeles, CA
Related Studies
- Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis ResearchRecruiting · University of Pittsburgh · Pittsburgh, Pennsylvania
- Studies of Skin Microbes in Healthy People and in People With Skin ConditionsRecruiting · National Human Genome Research Institute (NHGRI) · Bethesda, Maryland
- Natural History and Genetics of Food Allergy and Related ConditionsRecruiting · National Institute of Allergy and Infectious Diseases (NIAID) · Bethesda, Maryland
- An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)Recruiting · Regeneron Pharmaceuticals · Boston, Massachusetts